000			01857 a2200529 4500
005			20250514234811.0
264		0	_c20060105
008			200601s 0 0 eng d
022			_a0304-3959
024	7		_a10.1016/j.pain.2005.05.027 _2doi
040			_aNLM _beng _cNLM
100	1		_aLindia, Jill A
245	0	0	_aRelationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. _h[electronic resource]
260			_bPain _cSep 2005
300			_a145-53 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnalgesics _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aGanglia, Spinal _xcytology
650	0	4	_aImmunohistochemistry _xmethods
650	0	4	_aLamotrigine
650	0	4	_aMale
650	0	4	_aMexiletine _xtherapeutic use
650	0	4	_aNAV1.3 Voltage-Gated Sodium Channel
650	0	4	_aNerve Tissue Proteins _xgenetics
650	0	4	_aNeurons _xdrug effects
650	0	4	_aOligonucleotides _xadministration & dosage
650	0	4	_aPain _xdrug therapy
650	0	4	_aPain Measurement _xmethods
650	0	4	_aPeripheral Nerves _xmetabolism
650	0	4	_aPeripheral Nervous System Diseases _xcomplications
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSkin _xmetabolism
650	0	4	_aSodium Channels _xgenetics
650	0	4	_aTime Factors
650	0	4	_aTriazines _xtherapeutic use
650	0	4	_aUp-Regulation _xdrug effects
700	1		_aKöhler, Martin G
700	1		_aMartin, William J
700	1		_aAbbadie, Catherine
773	0		_tPain _gvol. 117 _gno. 1-2 _gp. 145-53
856	4	0	_uhttps://doi.org/10.1016/j.pain.2005.05.027 _zAvailable from publisher's website
999			_c15712741 _d15712741